Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

NCT03875729 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: teplizumab
BIOLOGICAL: Placebo

Sponsor

Provention Bio, Inc.